ID

25882

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Non-serious adverse event - Repeating form

Keywords

versioni (4)
  1. 24/09/17 24/09/17 -
  2. 04/10/17 04/10/17 -
  3. 23/10/17 23/10/17 -
  4. 26/12/17 26/12/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

24 settembre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Non-serious adverse event Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

Inglese

Non-serious adverse event Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli  
Non-serious adverse event
Descrizione

Non-serious adverse event

1. Sequence Number
Descrizione

[hidden]

Tipo di dati

text

2. Event
Descrizione

Diagnosis Only (if known) Otherwise Sign/Symptom

Tipo di dati

text

3. Modified term
Descrizione

[hidden]

Tipo di dati

text

MedDRA synonym
Descrizione

[hidden]

Tipo di dati

text

MedDRA lower level term code
Descrizione

[hidden]

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2826302
UMLS CUI [1,2]
C1518404
4. Start Date
Descrizione

Condition item Start Time is conditional. If times of intensity/toxicity change are being collected, AE start times must also be collected.

Tipo di dati

date

5. Outcome
Descrizione

Outcome

Tipo di dati

integer

5. End date
Descrizione

If outcome "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date.

Tipo di dati

date

6. Frequency
Descrizione

This item is optional

Tipo di dati

integer

7. Maximum Intensity
Descrizione

Record maximum intensity throughout duration of event. Optional item: This item may be hidden if either the Maximum Grade or Maximum Grade or Intensity item has been used.

Tipo di dati

text

8. Intensity at onset of event
Descrizione

Record intensity at the onset of the event [hidden]. Conditional item: Conditional on the use of the Intensity change section. If the section is not used then the item must be hidden. This item may be hidden if either the Grade/Grade or Intensity at onset of event item has been used.

Tipo di dati

text

9. Maximum Grade
Descrizione

Record maximum grade throughout duration of event [hidden]. Optional item: This item may be hidden if either the Maximum Intensity or Maximum Grade or Intensity item has been used. Grade 5 is optional.

Tipo di dati

integer

10. Grade at onset of event
Descrizione

Conditional item Conditional on using the Intensity change section. If the section is not used the item must be hidden. This item may be hidden if either the Intensity/Grade or Intensity at onset of event item has been used. Grade 5 is optional

Tipo di dati

integer

11. Maximum Grade or Intensity
Descrizione

Record maximum grade or intensity throughout duration of event [hidden]. Optional item: This item may be hidden if either the Maximum Intensity or Maximum Grade item has been used. Grade 5 is optional.

Tipo di dati

text

12. Grade or Intensity at onset of event
Descrizione

Record grade or intensity at the onset of the event [hidden]. Conditional item Conditional on the use of the Intensity change section. If the section is not used then the item must be hidden. This item may be hidden if either the Intensity or Grade at onset of event item has been used. Grade 5 is optional

Tipo di dati

text

13. Action Taken with Investigational Product(s) as a Result of the AE
Descrizione

Action Taken with Investigational Product

Tipo di dati

text

14. Did the subject withdraw from study as a result of this AE?
Descrizione

Withdrawal from study

Tipo di dati

boolean

15. Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descrizione

Use best judgment at initial entry. May be amended when additional information becomes available. If the study has multiple IP then remove Yes and keep Yes, select appropriate investigational product(s)' and set selection value to Y. Otherwise remove Yes, select appropriate investigational product(s) and keep Yes.

Tipo di dati

boolean

16. Duration of AE if < 24 hours (hours)
Descrizione

If AE start and end time are used this item must be hidden.

Tipo di dati

integer

Unità di misura
  • h
h
16. Duration of AE if < 24 hours (minutes)
Descrizione

If AE start and end time are used this item must be hidden.

Tipo di dati

integer

Unità di misura
  • min
min
17. Time to Onset Since Last Dose (hours)
Descrizione

[hidden] This item is optional

Tipo di dati

integer

Unità di misura
  • h
h
17. Time to Onset Since Last Dose (minutes)
Descrizione

[hidden] This item is optional

Tipo di dati

integer

Unità di misura
  • min
min
Ritorna all'inizio della pagina

Similar models

Non-serious adverse event Repeating form GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Non-serious adverse event
Sequence Number
Item
1. Sequence Number
text
Non-serious adverse event
Item
2. Event
text
Modified term
Item
3. Modified term
text
MedDRA synonym
Item
MedDRA synonym
text
MedDRA lower level term code
Item
MedDRA lower level term code
text
C2826302 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Start Date
Item
4. Start Date
date
Item
5. Outcome
integer
Outcome / End Date
Code List
5. Outcome
CL Item
Recovered/Resolved, provide End Date (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered/Resolved with sequelae, provide End Date (4)
End date
Item
5. End date
date
Item
6. Frequency
integer
Frequency
Code List
6. Frequency
CL Item
Single Episode (1)
CL Item
Intermittent (2)
Item
7. Maximum Intensity
text
Maximum Intensity
Code List
7. Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (X)
Item
8. Intensity at onset of event
text
Maximum Intensity
Code List
8. Intensity at onset of event
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (X)
Item
9. Maximum Grade
integer
Maximum Grade
Code List
9. Maximum Grade
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
10. Grade at onset of event
integer
Maximum Grade
Code List
10. Grade at onset of event
CL Item
Grade 1 (1)
CL Item
Grade 2 (2)
CL Item
Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
Item
11. Maximum Grade or Intensity
text
Maximum Grade or Intensity
Code List
11. Maximum Grade or Intensity
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (X)
Item
12. Grade or Intensity at onset of event
text
Maximum Grade or Intensity
Code List
12. Grade or Intensity at onset of event
CL Item
Mild or Grade 1 (1)
CL Item
Moderate or Grade 2 (2)
CL Item
Severe or Grade 3 (3)
CL Item
Grade 4 (4)
CL Item
Grade 5 (5)
CL Item
Not applicable (X)
Item
13. Action Taken with Investigational Product(s) as a Result of the AE
text
Action Taken with Investigational Product
Code List
13. Action Taken with Investigational Product(s) as a Result of the AE
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (X)
Withdrawal from study
Item
14. Did the subject withdraw from study as a result of this AE?
boolean
AE caused by investigational product
Item
15. Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
Duration of AE hours
Item
16. Duration of AE if < 24 hours (hours)
integer
Duration of AE minutes
Item
16. Duration of AE if < 24 hours (minutes)
integer
Time to Onset Since Last Dose hours
Item
17. Time to Onset Since Last Dose (hours)
integer
Time to Onset Since Last Dose minutes
Item
17. Time to Onset Since Last Dose (minutes)
integer
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial